" class="no-js "lang="en-US"> Artificial Intelligence Archives - Page 2 of 16 - Medtech Alert
Saturday, September 30, 2023

Sort by:


Top Post

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]

Tri-anim Health Services Announces Exclusive Relationship to Distribute Brainscope's Breakthrough Technology for Mild Head Injury Including Concussion, Into Emergency Departments

Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, […]

Ibex and Medipath Sign Multi-Year, Multi-Site and Multi-Tissue Expansion of AI for Cancer Diagnosis Across France

Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, and Medipath, the largest network of private […]

eCential Robotics Receives FDA Clearance for Its Surgical Robotic Platform for Spine Surgery

eCential Robotics, a French growth MedTech company that designs and produces a system unifying 2D/3D […]

NuraLogix Researchers Announce AI Models That Can Predict Blood Biomarker Risk

Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed […]

Athos Therapeutics Announces Proteomics Research Collaboration for Inflammatory Bowel Disease with Caltech

Athos Therapeutics, Inc. (“Athos”) is a late-stage preclinical biotech company using Artificial Intelligence (AI) to […]

UltraSight Receives CE Mark for Novel Cardiac AI Technology

UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, […]

GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development

GNS, the leader in the use of “Digital Twins” and Causal AI & biosimulation technology […]

AIRS Medical Raises $20M in Series B Funding

AIRS Medical, a healthcare startup based in South Korea and a member of the Born2Global Centre, recently announced that […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more